Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas - PubMed (original) (raw)
Comparative Study
Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas
M J Vidal et al. Melanoma Res. 1995 Aug.
Abstract
The WAF1 gene, located on chromosome 6p, encodes a M(r) 21,000 protein (p21) that can arrest cell growth by associating with and inhibiting cyclin-dependent kinase complexes that are necessary for cells to exit Gr. Transcriptional activation of WAF1 can be accomplished by increasing levels of p53 protein induced by various cellular stresses, including DNA damage. Metastatic melanomas are paradoxical in that most overexpress wild-type p53 protein, yet cell growth is not inhibited. Thus, it is possible that lack of growth suppression in melanomas is due, in part, to mutations in the WAF1 gene. Therefore, we examined the entire coding region of the WAF1 gene in 24 metastatic melanoma cell lines and three normal melanocyte lines by single-strand conformation polymorphism (SSCP) analysis and direct DNA sequencing. We similarly examined the DNA from lymphoblastoid cell lines, derived from nine individuals belonging to seven melanoma-prone families, in which haplotypes of markers on 6p cosegregate with melanoma for germline mutations in the WAF1 gene. Results indicate that (i) mutation of the WAF1 gene is an infrequent event in individuals with sporadic melanoma or predisposed to familial melanoma and (ii) the uncontrolled growth of melanoma cells is not due to mutation of the WAF1 gene. However, expression studies found a wide variation in the level of p21 protein in melanoma cells, suggesting that aberrant regulation of p21 may play a role in melanoma development. Moreover, there was no predictable relationship between p21 expression and p53 expression, indicating that other, p53-independent, pathways may be important for the regulation of p21 in melanoma cells.
Similar articles
- The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells.
Jiang H, Lin J, Su ZZ, Herlyn M, Kerbel RS, Weissman BE, Welch DR, Fisher PB. Jiang H, et al. Oncogene. 1995 May 4;10(9):1855-64. Oncogene. 1995. PMID: 7753561 - Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y, Zou M, Farid NR, al-Sedairy ST. Shi Y, et al. Br J Cancer. 1996 Nov;74(9):1336-41. doi: 10.1038/bjc.1996.546. Br J Cancer. 1996. PMID: 8912526 Free PMC article. - Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H. Ruggeri BA, et al. Cancer. 1997 Feb 15;79(4):700-16. Cancer. 1997. PMID: 9024708 - The Role of Caspases in Melanoma Pathogenesis.
Szmurło A, Dopytalska K, Szczerba M, Szymańska E, Petniak A, Kocki M, Kocki J, Walecka I. Szmurło A, et al. Curr Issues Mol Biol. 2024 Aug 28;46(9):9480-9492. doi: 10.3390/cimb46090562. Curr Issues Mol Biol. 2024. PMID: 39329914 Free PMC article. Review.
Cited by
- Tetrahydroanthraquinone Derivative (±)-4-Deoxyaustrocortilutein Induces Cell Cycle Arrest and Apoptosis in Melanoma Cells via Upregulation of p21 and p53 and Downregulation of NF-kappaB.
Genov M, Kreiseder B, Nagl M, Drucker E, Wiederstein M, Muellauer B, Krebs J, Grohmann T, Pretsch D, Baumann K, Bacher M, Pretsch A, Wiesner C. Genov M, et al. J Cancer. 2016 Mar 12;7(5):555-68. doi: 10.7150/jca.13614. eCollection 2016. J Cancer. 2016. PMID: 27053954 Free PMC article. - Differentiation-associated overexpression of the cyclin-dependent kinase inhibitor p21waf-1 in human cutaneous squamous cell carcinoma.
Tron VA, Tang L, Yong WP, Trotter MJ. Tron VA, et al. Am J Pathol. 1996 Oct;149(4):1139-46. Am J Pathol. 1996. PMID: 8863663 Free PMC article. - Transcriptional Targeting in Cancer Gene Therapy.
Robson T, Hirst DG. Robson T, et al. J Biomed Biotechnol. 2003;2003(2):110-137. doi: 10.1155/S1110724303209074. J Biomed Biotechnol. 2003. PMID: 12721516 Free PMC article. - Cyclin kinase inhibitor p21WAF1/CIP1 in malignant melanoma: reduced expression in metastatic lesions.
Maelandsmo GM, Holm R, Fodstad O, Kerbel RS, Flørenes VA. Maelandsmo GM, et al. Am J Pathol. 1996 Dec;149(6):1813-22. Am J Pathol. 1996. PMID: 8952518 Free PMC article. - Nevus senescence.
Ross AL, Sanchez MI, Grichnik JM. Ross AL, et al. ISRN Dermatol. 2011;2011:642157. doi: 10.5402/2011/642157. Epub 2011 Jun 22. ISRN Dermatol. 2011. PMID: 22363855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous